Viva Biotech (01873.HK) sincerely extends an invitation to you to attend the Viva Biotech Institutional Investors Conference. Recently, the Company has successfully introduced Temasek and HighLight Capital as strategic investors and announced its plan to spin off the CRO business for a separate listing on the A-share market. Taking this opportunity, the management team of Viva Biotech will join hands with strategic investors to share the Company’s financial performance, business highlights, long-term development strategies, and intrinsic value with you.

This conference will take place on 26th and 27th July 2023. The main content on both days will remain the same. The morning session will be presented in Mandarin, while the afternoon session will be presented in English. Please kindly choose the session that suits your schedule and language preference best. Thank you.